Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

626
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
626
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

739
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
739
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

943
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
943
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

463
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
463
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

905
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
905

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Meta-Analysis: Crohn's Disease Exclusion Diet for Induction and Maintenance in Crohn's Disease.

Alimentary pharmacology & therapeutics·2026
Same author

Comparative efficacy of advanced therapies in biological-exposed ulcerative colitis - a network meta-analysis of randomized trials.

European journal of gastroenterology & hepatology·2026
Same author

Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease.

Journal of Crohn's & colitis·2026
Same author

Caregiver burden in inflammatory bowel disease: a systematic review and meta-analysis.

BMC psychology·2026
Same author

Exclusive enteral nutrition for induction of remission in Crohn's disease in adults: A systematic review and meta-analysis of randomized trials and real-world studies.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

What are the top 10 global research priorities for perianal Crohn's disease? The Global Perianal Crohn's Disease Priority Setting Partnership.

Journal of Crohn's & colitis·2026

Related Experiment Video

Updated: Jan 12, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.4K

Systematic Review: Stigma Associated With Inflammatory Bowel Disease.

Suprabhat Giri1, Sidharth Harindranath2, Sanjay Chandnani3

  • 1Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India.

Alimentary Pharmacology & Therapeutics
|November 4, 2025
PubMed
Summary

Stigma significantly impacts inflammatory bowel disease (IBD) patients, affecting quality of life and treatment. Addressing stigma through awareness and support is crucial for improving patient outcomes and resilience.

Keywords:
Crohn's diseaseinflammatory bowel diseasestigmaulcerative colitis

More Related Videos

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

10.4K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.7K

Related Experiment Videos

Last Updated: Jan 12, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.4K
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

10.4K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.7K

Area of Science:

  • Gastroenterology
  • Psychology
  • Public Health

Background:

  • Stigma, encompassing perceived, enacted, and internalized forms, is a significant issue for individuals with inflammatory bowel disease (IBD).
  • This stigma negatively affects patients' quality of life, delays necessary medical treatment, and disrupts social interactions.
  • Understanding the multifaceted nature of IBD stigma is essential for developing effective interventions.

Purpose of the Study:

  • To conduct a comprehensive review of existing research on stigma associated with inflammatory bowel disease (IBD).
  • To summarize data regarding the prevalence, assessment methods, contributing factors, and consequences of stigma in the context of IBD.

Main Methods:

  • A systematic literature search was performed across major databases including MEDLINE, Embase, and Scopus.
  • The search covered studies reporting on the prevalence, assessment, predictors, and outcomes of stigma in IBD patients from the inception of the databases up to September 2025.
  • A total of 73 studies were analyzed to synthesize the findings on IBD stigma.

Main Results:

  • Significant heterogeneity exists in stigma assessment methods due to the absence of standardized scales.
  • Perceived stigma is highly prevalent, affecting up to 85.6% of adults and 87% of children with IBD.
  • Stigma manifests as fear of judgment, body image concerns, relationship difficulties, and workplace discrimination, with lower reported rates for enacted and internalized stigma.

Conclusions:

  • The review underscores the need for standardized research methods to accurately assess stigma in IBD.
  • Increased public awareness and knowledge about IBD are vital to reduce stigma.
  • Interventions focused on enhancing patient resilience and coping mechanisms are recommended to mitigate the negative impacts of stigma.